Congenital Heart Disease Clinical Trials in Boston, Massachusetts

6 studies are recruiting for congenital heart disease in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

   Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through tha…

   Stage

   Not phased

   Ages

   Up to 0

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Locations

   10 in total

   Run by

   Starlight Cardiovascular Inc

   See if you can join NCT07114718 on ClinicalTrials.gov

2. Autus Valve Continued Access Study (CAS)

   Prospective, single-arm, multi-center, continued access study of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years requiring surgical pulmonary valve replacement. The Autus Valve may be expanded pre-implant to match the subject's body size. Subjects will be evaluated …

   Stage

   Not phased

   Ages

   1 to 16

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Locations

   10 in total

   Run by

   Edwards Lifesciences

   See if you can join NCT07466745 on ClinicalTrials.gov

3. Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery in Children

   The goal of this study is to evaluate the impact of a clinical decision support system (CDSS) in children receiving mechanical ventilation (MV) after surgery for congenital heart disease (CHD). The main question it aims to answer is: -What is the impact of a CDSS designed to facilitate weaning and …

   Stage

   Not phased

   Ages

   0 to 12

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Run by

   Boston Children's Hospital

   See if you can join NCT05687292 on ClinicalTrials.gov

4. Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis

   Newborns with congenital heart disease (CHD) are at increased risk of developing postpartum and postoperative blood clots after cardiac surgery. The molecular mechanisms that are responsible for the clotting profile predisposing children to blood clots in the early stages of life are currently not …

   Stage

   Not phased

   Ages

   0 to 0

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Run by

   Boston Children's Hospital

   See if you can join NCT06434207 on ClinicalTrials.gov

5. Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac Surgery

   The goal of this proposal is to prospectively collect data from a series of 200 patients (all ages) undergoing complex cardiac surgical procedures involving cardiopulmonary bypass (CPB) to: 1. Measure the number of blood activated circulating monocytes before, during and after cardiac surgery and s…

   Stage

   Not phased

   Ages

   Any age

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Run by

   Boston Children's Hospital

   See if you can join NCT04299828 on ClinicalTrials.gov

6. Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease

   In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysi…

   Stage

   Not phased

   Ages

   13 and older

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Run by

   Boston Children's Hospital

   See if you can join NCT05241418 on ClinicalTrials.gov